Related content

Atypical IgM multiple myeloma with deletion of c‐MAF

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 686-689

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple Myeloma

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 13, Iss. 1, 2013-01 ,pp. : 16-34

Bentham Science Publishers

Access to resources Recommend Favorite

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide

By Witzens Mathias  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 467-470

Springer Publishing Company

Access to resources Recommend Favorite

Multiple myeloma and mycosis fungoides in the same patient: clinical, immunologic, and molecular studies

By Gernone A.   Frassanito M.   Pellegrino A.   Vacca A.   Dammacco F.  

Annals of Hematology, Vol. 81, Iss. 6, 2002-06 ,pp. : 326-331

Springer Publishing Company

Access to resources Recommend Favorite

Neurofibromatosis type I and smoldering multiple myeloma: A case report

By Danilatou Vassiliki   Liapi Demetra   Psyllaki Maria   Chatzivasili Aria   Chronaki Irini   Heliakis Polyvios  

Hematology, Vol. 11, Iss. 1, 2006-02 ,pp. : 45-48

Maney Publishing

Access to resources Recommend Favorite